Brainstem hypoxia contributes to the development of hypertension in the spontaneously hypertensive rat. by Marina, N et al.
775
Hypertension is one of the main risk factors for the devel-opment of many cardiovascular diseases. Despite signifi-
cant progress in the diagnosis and treatment of hypertension, 
approximately only half of patients show satisfactory response 
to treatment.1 This poor efficacy might be because of the fact 
that conventional antihypertensive therapies are aimed at 
downstream peripheral mechanisms which maintain high sys-
temic arterial blood pressure, while primary factors respon-
sible for the development of the condition remain untreated.
The pathophysiology of systemic arterial hypertension is com-
plex and in general poorly understood, but over the last 3 decades 
studies in animal models and patients with hypertension have 
provided significant evidence that activation of the sympathetic 
nervous system is linked to the development and maintenance 
of the condition.2–4 Vasomotor and cardiac activities of spinal 
sympathetic preganglionic neurons depend on tonic descending 
excitatory drive generated by sympathoexcitatory (presympa-
thetic) neuronal networks residing in the hypothalamus and the 
brainstem5–9: the rostral ventrolateral medulla (RVLM), rostral 
ventromedial and midline medulla, the A5 cell group of the pons, 
and the paraventricular hypothalamic nucleus.6,8,10–12 Bulbospinal 
neurons of the RVLM which belong to the catecholaminergic C1 
group are believed to be of a prime importance for the mainte-
nance of vasomotor sympathetic tone.12
One of the potential mechanisms which may be responsible 
for sympathetic activation in hypertension is based on the oper-
ation of a so-called Cushing response characterized by a triad 
of high blood pressure, irregular breathing, and bradycardia.13 
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Although originally described as an autoresuscitation mecha-
nism recruited under extreme pathological conditions such as 
brain ischemia, it is currently viewed as a physiological com-
pensatory response to compromised brain perfusion or brain 
hypoxia.14,15 Brainstem vasculature of patients with hyperten-
sion and of animal models of hypertension (eg, spontaneously 
hypertensive rat [SHR]) is considerably narrower (compared 
with the respective normotensive counterparts), resulting in 
high cerebral artery resistance.16,17 This is not a consequence 
of hypertension as it occurs prior to its development, at least in 
the SHR.16 Thus, the neuronal sympathoexcitatory networks 
that control the arterial blood pressure have been suggested to 
be hypoperfused/hypoxic.16,18 By increasing systemic arterial 
blood pressure in response to compromised brainstem perfu-
sion, the Cushing mechanism would be expected to produce 
changes in the circulatory system to preserve oxygen delivery 
and maintain brain oxygenation at the expense of systemic 
hypertension.15,16,18,19
The mechanisms underlying sympathetic activation associated 
with compromised brain tissue perfusion and hypoxia remain 
unknown. Presympathetic RVLM neurons are highly sensi-
tive to hypoxia,20–22 but the mechanisms of their O2 sensitivity 
have never been addressed. Brain tissue hypoxia is expected to 
be associated with increases in the level of extracellular lactate, 
which was recently shown to have a profound excitatory effect 
on another notable population of brainstem catecholaminergic 
neurons residing in the pontine locus coeruleus.23 In addition, 
we have previously shown that hypoxia triggers release of ATP 
within the RVLM.24 Other pharmacological studies have revealed 
that activation of ATP receptors in the RVLM by microinjections 
of ATP or stable ATP analogues increases the excitability of C1 
neurons and leads to the increases in the arterial blood pressure, 
heart rate, and renal sympathetic nerve activity.25–27
This study was designed to test the hypothesis that brainstem 
hypoxia is associated with the pathogenesis of systemic arte-
rial hypertension. We measured oxygen tension from within 
the presympathetic RVLM region of the brainstem in the SHRs 
and control Wistar rats, determined whether oxygen sensitivity 
of presympathetic C1 neurons is direct or mediated by prior 
release and actions of ATP and lactate, evaluated the effects of 
l-lactate on sympathetic nerve activity and the arterial blood 
pressure, and determined the effect of blocking ATP-mediated 
signaling in the RVLM on systemic arterial blood pressure in 
the SHRs and their normotensive counterparts.
Methods
All animal experimentations were performed in accordance with the 
European Commission Directive 86/609/EEC (European Convention 
for the Protection of Vertebrate Animals used for Experimental and 
Other Scientific Purposes) and the UK Home Office (Scientific 
Procedures) Act (1986) with project approval from the respective 
Institutional Animal Care and Use Committees. Detailed description 
of the Materials and Methods used in the current study is available in 
the online-only Data Supplement.
Results
Brainstem of the SHR Is Hypoxic at Normal Levels 
of the Arterial Blood Pressure
At baseline conditions, ventrolateral medullary PO2 in anes-
thetized SHRs was found to be slightly lower compared with 
their age- and sex-matched normotensive Wistar rats (18±3 
mm Hg [n=5] versus 26±4 mm Hg [n=6]; P=0.07; Figure 1B). 
When the arterial blood pressure of anesthetized SHRs was 
lowered to the level of normotensive Wistar rats (from 144±3 
mm Hg to 93±1 mm Hg) by intravenous infusion of sodium 
nitroprusside (arterial PO2 level was kept at ≈100 mm Hg), 
brainstem PO2 decreased to 11±1 mm Hg (P=0.006, paired t 
test, RVLM PO2 in the SHRs at baseline versus in normoten-
sive conditions; Figure 1B). When mean arterial blood pres-
sure of Wistar rats was increased to the level of SHRs (from 
97±1 mm Hg to 145±5 mm Hg) by intravenous infusion of 
vasopressin (while keeping arterial PO2 level at ≈100 mm Hg), 
brainstem PO2 increased to 35±3 mm Hg (P=0.019, paired t 
test, RVLM PO2 in Wistar rats at baseline versus in hyper-
tensive conditions; Figure 1B). Thus, resting RVLM PO2 in 
SHRs is lower than that of hypertensive Wistar rats (P=0.006, 
unpaired t test; Figure 1B), and resting RVLM PO2 in Wistar 
rats is higher than that of normotensive SHRs (P=0.025, 
unpaired t test; Figure 1B). Similar data were obtained when 
tissue PO2 measurements were taken from within the dorsal 
medullary nucleus of the solitary tract. Baseline PO2 in the 
Figure 1. Brainstem of the spontaneously hypertensive rat 
(SHR) is hypoxic at physiological levels of the systemic arterial 
blood pressure. A, Schematic drawing of the rat brain in sagittal 
projection illustrating the site of PO2 measurements taken from 
the anatomic location of the presympathetic circuits of the 
rostral ventrolateral medulla (RVLM). B, Summary data showing 
parenchymal PO2 levels in the RVLM of anesthetized SHRs 
and Wistar rats. PO2 measurements were taken before and 
during intravenous infusion of sodium nitroprusside (SNP) and 
vasopressin (VP) in SHRs and Wistar rats, respectively. Data 
are presented as means±SEM. Note that because the arterial 
blood pressure in these experiments was clamped, SE values 
are small and the respective error bars are embedded within 
the symbols. Paired t test: RVLM PO2 in Wistar rats, resting vs 
vasopressin (*P=0.019); RVLM PO2 in SHRs, resting vs SNP 
(**P=0.006). Unpaired t test: RVLM PO2 in SHRs vs hypertensive 
Wistar rats (#P=0.006); RVLM PO2 in normotensive Wistar rats vs 
normotensive SHRs (##P=0.025).
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nucleus of the solitary tract of anesthetized SHRs (n=3) was 
16±2 mm Hg decreasing to 8±3 mm Hg (P<0.05, paired t test) 
when the arterial blood pressure was lowered to the normo-
tensive level. In age- and sex-matched normotensive Wistar 
rats (n=3), baseline nucleus of the solitary tract PO2 was 19±3 
mm Hg (n=3) increasing to 30±5 mm Hg (P<0.05, paired t 
test) when blood pressure was increased to the level recorded 
in the SHRs. These data confirm that the level of the arterial 
blood pressure determines PO2 of the brainstem parenchyma. 
The data also demonstrate that the brainstem PO2 in the SHR 
is ≈15 mm Hg lower than in the Wistar rat at the same level of 
the systemic arterial blood pressure.
Figure 2. Release and actions of ATP and lactate mediate activation of rostral ventrolateral medulla (RVLM) neurons during hypoxia. A, 
Summary data obtained in vitro using horizontal slices of the rat brainstem showing tonic release of lactate from the ventral surface of 
the medulla oblongata and peak lactate release during hypoxia. Inset, Schematic drawing of a horizontal brainstem slice illustrating dual 
recording configuration of lactate and null (control) biosensors placed on the ventral medullary surface. Difference in current between 
lactate and null biosensors was used to determine the amount of lactate release. py, pyramidal tract; XII hypoglossal rootlets. B, Putative 
presympathetic C1 RVLM neurons visualized in organotypic brainstem slices after transduction with an adenoviral vector to express 
genetically encoded Ca2+ indicator TN-XXL under the control of PRSx8 promoter. C, Raw traces (changes in intracellular [Ca2+] of 2 
individual neurons are shown on each plot) illustrating robust and reproducible responses of the RVLM neurons to hypoxia (upper plot) 
as well as the effects of ATP receptor antagonist MRS2179 (30 µmol/L) (middle) and glycogenolysis inhibitor 1,4-dideoxy-1,4-imino-
d-arabinitol (DAB) (500 µmol/L) (bottom) on hypoxia-induced [Ca2+]i responses of these neurons (ratiometric imaging using TN-XXL). 
D, Summary data illustrating the effects of MRS2179 and DAB on hypoxia-induced [Ca2+]i responses of putative C1 neurons. Data are 
presented as means±SEM.
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ATP and Lactate Mediate Excitation of RVLM 
Neurons at Low PO2
We next determined whether the sensitivity of RVLM neu-
rons to hypoxia is direct or mediated by prior release and 
actions of ATP or lactate or both. In the acute brainstem 
slices of adult Wistar rats, hypoxia was associated with 
facilitated release of lactate (Figure 2A). Lactate biosen-
sors placed in a direct contact with the ventral surface of 
the medulla oblongata detected tonic release of lactate 
of 396±58 µmol/L increasing to 507±71 µmol/L dur-
ing 4 minutes of hypoxia (n=10; P<0.001, paired t test; 
Figure 2A). We demonstrated previously that release of 
ATP in the brainstem is also facilitated during hypoxia,24 
and the next experiment examined whether the sensitivity 
of RVLM neurons to low PO2 is dependent on ATP- and 
lactate-mediated signaling.
Hypoxia-induced [Ca2+]i responses in putative C1 neurons 
were visualized in organotypic brainstem slices using the 
genetically encoded Ca2+ indicator TN-XXL expressed under 
the control of the PRSx8 promoter (Figure 2B). Confirming 
previously reported data,20,21 hypoxia triggered robust and 
reproducible [Ca2+]i elevations in 100% of the recorded neu-
rons (Figure 2C). Hypoxia-induced [Ca2+]i responses of these 
putative C1 neurons were markedly reduced in the presence 
of an ATP receptor antagonist MRS2179 (30 µmol/L; n=19, 
P=0.005, paired t test; Figure 2C and 2D) or after incubation 
of the slice with glycogenolysis inhibitor 1,4-dideoxy-1,4-im-
ino-d-arabinitol (500 µmol/L; n=13, P=0.005, paired t test; 
Figure 2C and 2D). These data suggest that oxygen sensitivity 
of RVLM neurons is not intrinsic but indirect, and mediated 
by actions of ATP and lactate released from as yet unknown 
cellular source, but most likely astrocytes.23,28,29
Figure 3. l-Lactate activates rostral ventrolateral medulla (RVLM) neurons in vitro and induces increases in the sympathetic nerve activity 
and the arterial blood pressure in vivo. A, Putative C1 neurons in organotypic brainstem slice culture transduced to express enhanced 
green fluorescent protein under the control of PRSx8 promoter and visualized for patch clamp recordings. B, Representative trace of 
the membrane potential changes and electrical activity of a putative C1 neuron showing depolarization and increased rate of action 
potential firing in response to application of l-lactate (2 mmol/L, pH 7.4). C, Representative trace and summary data (right) illustrating 
[Ca2+]i responses of putative C1 neurons to application of l-lactate (2 mmol/L, pH 7.4) and KCl (20 mmol/L) (ratiometric imaging using 
TN-XXL). D, Raw data obtained in anesthetized and artificially ventilated rat showing changes in heart rate, arterial blood pressure, and 
sympathetic nerve activity induced by l-lactate (20 mmol/L, pH 7.4) applied on the ventral surface of the medulla oblongata. E, Summary 
data illustrating the effect of l-lactate applied on the ventral surface of the medulla oblongata on systolic blood pressure (SBP), diastolic 
blood pressure (DBP), heart rate (HR) and renal sympathetic nerve activity (RSNA). Data are presented as means±SEM. BP indicates 
arterial blood pressure.
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l-Lactate Activates RVLM Neurons In Vitro and 
Induces Increases in the Sympathetic Nerve Activity 
and the Arterial Blood Pressure In Vivo
Putative C1 neurons recorded in organotypic brainstem 
slices (Figure 3A) responded to bath application of l-lac-
tate (2 mmol/L, pH 7.4) with sustained depolarization (V
m
 
increased from −62±5 mV to −56±5 mV, n=4, P=0.006, 
paired t test) and increased rate of action potential firing 
(Figure 3B). l-lactate (2 mmol/L) also triggered robust 
[Ca2+]i elevations in ≈60% (8 of 12 neurons that responded 
to KCl, 20 mmol/L) of the recorded putative C1 neurons 
expressing TN-XXL (Figure 3C). Lactate-induced [Ca2+] 
elevations in RVLM neurons were remarkably strong (aver-
age peak of the response reaching 80% of that triggered by 
KCl) with a complete recovery within ≈5 minutes of lac-
tate washout (Figure 3C). In pentobarbital-anesthetized and 
artificially ventilated normotensive Wistar rats (end-tidal 
CO2 was kept at ≈3.5±0.5% throughout the experiments), 
application of l-lactate (20 mmol/L, 30 µL) on the ventral 
surface of the medulla oblongata induced profound and sus-
tained (lasting for at least 10 minutes) sympathoexcitatory 
response, characterized by significant increases in renal 
sympathetic nerve activity (by 66±18%, P=0.009, paired t 
test), systolic arterial blood pressure (from 106±2 to 131±8 
mm Hg, P=0.002, paired t test), diastolic arterial blood pres-
sure (from 52±5 to 68±4 mm Hg, P=0.002, paired t test), and 
heart rate (from 376±26 to 398±24 beats min−1, P=0.001, 
paired t test; Figure 3D and 3E). These data are consistent 
with recent observations showing that central catecholamin-
ergic neurons are highly sensitive to lactate23 and suggest that 
higher levels of ambient lactate in the RVLM may contribute 
to the increased activity of presympathetic C1 bulbospinal 
Figure 4. Transmembrane prostate acidic phosphatase (TMPAP) expression in the rostral ventrolateral medulla (RVLM) reduces the 
degree of hypertension in the spontaneously hypertensive rat (SHR). A, TMPAP–enhanced green fluorescent protein (EGFP) expression 
in the C1 region of the RVLM (TH, tyrosine hydroxylase). Bottom image is a high magnification micrograph showing a proportion of TH-
positive neurons expressing TMPAP-EGFP. B, Schematic drawing of the rat brainstem in a series of coronal projections illustrating the 
representative extent of TMPAP expression in relation to the anatomic location of the RVLM presympathetic circuits. Numbers indicate 
distance from Bregma. TMPAP expression was highest in the ventrolateral medullary regions located at −11.80 mm from Bregma. C, 
Summary data showing that bilateral expression of TMPAP-EGFP within the C1 region of the RVLM results in a significant reduction of 
the arterial blood pressure in the SHR. The effect was sustained for 3 weeks. Note that TMPAP expression in the RVLM had no effect on 
the arterial blood pressure in Wistar rats. Data are presented as means±SEM. *Significant difference between SHRs expressing EGFP and 
SHRs expressing TMPAP-EGFP in the RVLM (P<0.05).
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vasomotor neurons and concomitant sympathetic activation 
and hypertension observed in the SHR.
Facilitated Breakdown of Extracellular ATP  
in the RVLM Reduces the Degree of  
Hypertension in the SHR
In the SHR, overexpression of a potent ectonucleotidase, 
transmembrane prostate acidic phosphatase (TMPAP), 
within the C1 area of the RVLM (Figure 4A and 4B; to 
promote facilitated ATP breakdown) was associated with 
a significant reduction in systemic arterial blood pres-
sure (Figure 4C). This effect was maintained for 3 weeks 
of TMPAP expression in the RVLM [mean arterial blood 
pressure was 116±9 mm Hg (n=7) in the SHRs express-
ing TMPAP in the RVLM versus 153±8 mm Hg (n=9) in 
the SHRs expressing enhanced green fluorescent protein; 
P=0.009, Kruskal–Wallis ANOVA by ranks]. There were 
no differences in mean arterial blood pressure between 2 
groups of SHRs 5 weeks after the injections of TMPAP 
or enhanced green fluorescent protein–expressing viral 
vectors (Figure 4C). TMPAP expression and activity in 
the RVLM had no effect on the arterial blood pressure of 
Wistar rats [TMPAP: 91±4 mm Hg (n=8) versus enhanced 
green fluorescent protein: 93±4 mm Hg (n=8); P=0.836, 
Kruskal–Wallis ANOVA by ranks]. Immunohistochemical 
analysis identified a proportion of tyrosine hydroxy-
lase–positive (C1) RVLM neurons expressing TMPAP 
(Figure 4A) and a general strong expression of the trans-
gene along the rostro-caudal extent of the RVLM (between 
−11.60 and −12.80 mm from Bregma; Figure 4B). Thus, 
TMPAP expression and facilitated breakdown of ATP in 
the RVLM lowers arterial blood pressure in the SHR with-
out affecting this hemodynamic variable in control ani-
mals, suggesting that ATP-mediated signaling contribute 
to the maintenance of systemic arterial hypertension in 
this model.
Discussion
This study tested the hypothesis that brainstem hypoxia 
contributes to the pathogenesis of systemic arterial 
hypertension. This hypothesis is difficult to test directly 
as this would require an experimental paradigm allow-
ing differential precise manipulation of peripheral and 
cerebral oxygenation at different stages of development, 
including young prehypertensive SHRs. However, our 
evidence strongly supports the hypothesis. We found 
that the brainstem of the adult SHR is hypoxic (PO2≈10 
mm Hg) at physiological levels of the arterial PO2 (100 
mm Hg) and systemic arterial blood pressure (mean ≈95 
mm Hg). PO2 measurements were taken from within the 
brainstem region that contains a major group of RVLM 
bulbospinal sympathoexcitatory (presympathetic) C1 
neurons which generate vasomotor sympathetic tone.7,12,30 
These neurons are known to be excited by low Po2,20,21,31 
and our data indicate that their sensitivity to hypoxia is 
(at least partially) indirect (ie, nonintrinsic) and mediated 
by prior release and actions of ATP and lactate. Tissue 
hypoxia always leads to lactate release/accumulation32 
(we confirm this in the current study, see Figure 2A), and 
here we demonstrate that lactate is capable of increasing 
the activity of RVLM neurons. We also found that appli-
cation of lactate to the ventral surface of the brainstem 
in normotensive animals produces profound sympatho-
excitation and increases in the arterial blood pressure. 
Hypoxia-evoked release of ATP and ATP stimulatory 
actions on C1 neurons, central sympathetic drive, and 
systemic arterial blood pressure have been demon-
strated previously.24,25,27 Finally, in the SHR, blockade 
of ATP-mediated signaling in the RVLM presympathetic 
area by virally-driven overexpression of a potent ecto-
nucleotidase (TMPAP), resulted in a significant lower-
ing of the arterial blood pressure—the effect which was 
sustained for 3 weeks. The aim of this experiment was 
to achieve widespread and strong transgene expression 
in the general RVLM area. This would ensure effective 
ATP breakdown and blockade of ATP-mediated para-
crine (volume) signaling. Although, only a proportion 
of the RVLM C1 neurons was transduced, expression of 
TMPAP by other cellular elements in the area was clearly 
sufficient to achieve significant reduction of the arterial 
blood pressure in the SHR. Together these data suggest 
that decreased parenchymal PO2 in the RVLM leads to 
higher levels of ambient ATP and lactate which increase 
the excitability of RVLM neurons, leading to enhanced 
vasomotor sympathetic tone and high systemic arterial 
blood pressure. We propose that in the SHR this serves as 
a compensatory condition needed to maintain adequate 
blood supply and oxygenation of the brain.
Several previous studies have shown that cerebral vascu-
lar resistance is high in patients with hypertension as well as 
in animal models of hypertension, including the SHRs.14–17,33 
In rats, increasing cerebral vascular resistance was shown to 
raise sympathetic activity and the arterial blood pressure.16 
Moreover, in the SHR, development of hypertension is asso-
ciated with progressive impairment of neurovascular cou-
pling, elevated baseline capillary red blood cell velocity,34 and 
impaired autoregulation because of vascular hypertrophy.35 
Our data are consistent with these observations and directly 
demonstrate that the brainstem of SHRs becomes hypoxic 
when systemic arterial blood pressure decreases to physi-
ological levels.
Histological analysis revealed robust TMPAP expression 
in the RVLM even at 6 weeks after the delivery of viral 
vectors (not shown). Therefore, fading TMPAP expres-
sion and declining activity are unlikely to be responsible 
for the recovery of the hypertensive phenotype in the SHR. 
Although TMPAP activity is effective in reducing systemic 
arterial blood pressure, our oxygen measurements sug-
gest that this would also result in reduced cerebral oxy-
genation. We hypothesize that compensation is likely to 
develop over time to restore high arterial blood pressure by 
either recruitment of other mechanisms driving the activ-
ity of RVLM presympathetic neurons or by enhanced activ-
ity of presympathetic neurons residing in other regions of 
the central nervous system, not targeted to express TMPAP 
(eg, paraventricular nucleus). Moreover, at later stages of 
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hypertension development in this model, other factors (renal 
and vascular) may become more significant in maintenance 
of the condition.
Earlier in vivo and in vitro studies have demonstrated that 
presympathetic C1 neurons are highly sensitive to hypoxia 
(or chemical hypoxia induced by CN− application).20,21,36–38 
Confirming these reports, hypoxia was found to trigger robust 
and reproducible [Ca2+]i elevations in 100% of the recorded 
RVLM neurons. Hypoxia-induced responses in these puta-
tive C1 neurons were reduced to a similar extent either in the 
presence of an ATP receptor antagonist MRS2179 (which 
is acting preferentially at metabotropic P2Y1 receptors) or 
after incubation of the slice with glycogenolysis inhibitor 
1,4-dideoxy-1,4-imino-d-arabinitol. These data suggest that 
sensitivity of C1 neurons to decreases in PO2 is mostly indi-
rect and mediated by prior release and actions of ATP and 
lactate. In this study, we demonstrate directly that hypoxia 
leads to a significant increase in lactate efflux detected at 
the ventral surface of the brainstem, whereas our previous 
study reported profound hypoxia-induced release of ATP in 
the medulla oblongata—an effect observed in anesthetized 
and artificially ventilated rats and in acute brainstem slices 
in vitro.24
C1 neurons are known to be sensitive to ATP. ATP or 
stable ATP analogues increase their activity, triggers sym-
pathoexcitation, and increases arterial blood pressure in 
normotensive rats.25,27,39 A role of purinergic signaling in 
modulating the activity of RVLM presympathetic circuits 
is also supported by a more recent evidence showing that 
P2Y1 receptor-mediated activation of C1 neurons contrib-
utes to sympathetic and blood pressure responses elicited by 
activation of the peripheral chemoreceptors.40 Furthermore, 
ATP-mediated signaling may also contribute to alterations 
in the central nervous mechanisms of autonomic control and 
development of hypertension in rats subjected to chronic 
intermittent hypoxia. This animal model shows significantly 
increased expression of ionotropic ATP receptors (P2X3 and 
P2X4 subunits in particular) in the RVLM41 and markedly 
enhanced sympathetic responses to microinjections of ATP 
into the RVLM.42
Responses of the RVLM neurons to lactate application 
were found to be similar in magnitude and time course to 
those observed recently in neurons of the pontine locus 
coeruleus, a major cluster of catecholaminergic cells in the 
central nervous system.23 Lactate is produced by activated 
astroglial cells and stimulates neurons of the locus coeruleus 
to release norepinephrine, and these effects are mimicked 
by application of exogenous lactate.23 As expected, hypoxia 
triggered release of lactate in the ventrolateral medulla 
(Figure 2A), and lactate produced potent sympathoexcit-
atory responses in vivo (Figure 3). We propose that inter-
fering with lactate-mediated signaling could be a potential 
therapeutic strategy that may help to attenuate pathological 
sympathoexcitation associated with systemic arterial hyper-
tension; however, because of current unavailability of a suit-
able blocker of lactate actions, we were not able to test this 
hypothesis in this study.
Nonexcitable cells in the brain (eg, astrocytes) communicate 
predominantly via release of ATP.28,29,43 Astrocytes are also the 
only type of brain cell which store glycogen44 and according to 
the lactate shuttle hypothesis45 supply energy to neurons in the 
form of lactate. Although the identity of cells which release 
ATP and lactate responsible for hypoxia-induced activation of 
RVLM neurons remains unknown, astroglia represents a plau-
sible source. Astrocytes can detect various sensory modalities 
such as changes in brain parenchymal pH and glucose lev-
els.28,46 C1 neurons are activated when RVLM astrocytes are 
selectively stimulated using an optogenetic approach.43 These 
astrocyte-driven responses of C1 neurons were found to be 
abolished in the presence of an ATP-degrading enzyme apy-
rase, suggesting that ATP mediates communication between 
astrocytes and these presympathetic neurons.43 Furthermore, 
in vivo experiments conducted in anesthetized and artificially 
ventilated rats showed that optogenetic stimulation of RVLM 
astrocytes increases sympathetic nerve activity and systemic 
arterial blood pressure.43
A major clinical problem associated with hypertension 
is stroke. Many strokes develop as a consequence of brain 
ischemia rather than hemorrhage. It is of interest that there 
is a significant association between hypertension before 
and after posterior cerebral artery infarction compared with 
anterior cerebral artery infarction.17 These observations 
in humans further support the hypothesis that brainstem 
hypoperfusion/hypoxia is an important contributor to the 
development of hypertension. Whether this is also the case 
in other cardiovascular diseases where central sympathetic 
drive is high is not known. However, we have recently 
shown that a similar mechanism involving facilitated 
ATP-mediated signaling in the RVLM contributes to sym-
pathetic activation during the development of myocardial 
infarction-induced heart failure.43 Interestingly, a recent 
study using cerebral oximetry has demonstrated that cere-
bral tissue oxygen saturation in many heart failure patients 
is low, despite nearly normal levels measured in the arte-
rial blood.47 It seems that the same mechanism activated 
by brainstem hypoxia might be responsible for heightened 
central sympathetic tone in both heart failure and systemic 
arterial hypertension.
Perspectives
The data obtained in the present study suggest that in the SHR 
low parenchymal PO2 results in higher levels of ambient ATP 
and lactate within the presympathetic areas of the brainstem 
leading to the increased activity of sympathoexcitatory neu-
rons and concomitant sustained increases in the arterial blood 
pressure.
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What Is New?
•	Brainstem parenchymal oxygen tension in the spontaneously hyperten-
sive rat is ≈15 mm Hg lower than in the normotensive Wistar rat at the 
same level of arterial oxygenation and systemic arterial blood pressure.
•	Hypoxia-induced activation of presympathetic brainstem circuits is me-
diated by actions of ATP and lactate released in low PO
2
 conditions.
•	Sustained blockade of ATP-mediated signaling within the presympa-
thetic brainstem circuits results in a significant decrease in systemic 
arterial blood pressure in the spontaneously hypertensive rat (but not in 
normotensive animals).
•	These findings are the first of its kind to provide a fundamental insight 
into the mechanisms that link central nervous system hypoxia, increased 
sympathetic activity, and high systemic arterial blood pressure.
What Is Relevant?
•	Brainstem hypoxia contributes to the development of systemic arterial 
hypertension.
•	Signaling pathways activated by central hypoxia represent a potential 




 of the brainstem parenchyma may be associated with 
higher levels of ambient ATP and lactate within the presympa-
thetic circuits, leading to increased central sympathetic drive 
and concomitant sustained increases in the arterial blood pres-
sure.
Novelty and Significance
